Article Details

Replimune Announces First Patient Dosed with RP3 in a Phase 1 Clinical Trial in Patients with ...

Retrieved on: 2021-01-05 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Replimune Announces First Patient Dosed with RP3 in a Phase 1 Clinical Trial in Patients with .... View article details on hiswai:

Excerpt

Replimune's product candidates are designed to comprehensively activate an anti-tumor immune response to a patient's cancer through the delivery of ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up